CSBR Latest News

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy

accessnewswire.com — Mar 30, 2026

Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D HACKENSACK, NJ / ACCESS Newswire

Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript

seekingalpha.com — Mar 12, 2026

Champions Oncology, Inc.

Champions Oncology Reports Revenue of $16.6 Million

accessnewswire.com — Mar 12, 2026

Company remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for the fiscal year HACKENSACK, NJ / ACCESS Newswire /

Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026

accessnewswire.com — Mar 5, 2026

HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will repo